Strata Skin Sciences, Inc. SSKN
0.01
0.00
0.00%
as of 25 Sep
- Market cap
- $1.0M
- P/E
- 0.0×
Follow SSKN
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Mar '25 | Jun '25 | Sep '25 | Dec '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(151.23%) | (235.41%) | (208.09%) | (158.91%) | |
| (24.63%) | (32.83%) | (31.27%) | (19.13%) | ||
ROIC |
(52.10%) | (65.80%) | (63.41%) | (28.40%) | |
Return on Tangible Assets |
(89.71%) | (137.81%) | (126.06%) | 287.60% | |
Average Days of Receivables |
54.36 | 44.69 | 41.28 | 49.00 | |
Free Cash Flow per Share |
(0.16) | (0.67) | (0.78) | (0.92) | |
Free Cash Flow |
(0.67) | (2.79) | (3.51) | (4.26) | |
Capital Expenditures |
(1.11) | (0.70) | (1.66) | (1.47) | |
Piotroski F-Score |
5.00 | 3.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
1.72% | (9.70%) | (7.81%) | (10.68%) | |
Accounts Receivable Turnover |
7.79 | 8.21 | 7.80 | 6.55 | |
Accounts Payable Turnover |
4.32 | 4.71 | 5.51 | 4.94 | |
Inventory Turnover |
5.17 | 4.63 | 4.47 | 5.07 | |
Average Days of Payables |
74.31 | 78.29 | 83.20 | 78.55 | |
Days of Inventory on Hand |
70.17 | 86.03 | 86.10 | 80.15 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.20% | 1.90% | 1.79% | 1.37% | |
Selling, General and Administrative Expense of Revenue |
68.90% | 74.11% | 76.07% | 75.89% | |
Share Based Compensation of Revenue |
1.32% | 1.25% | 1.92% | 2.09% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.05) | 0.18 | 0.17 | 0.45 | |
Depreciation/Fixed assets |
0.57 | 0.63 | 0.53 | 0.52 | |
Capex/Depreciation |
(0.20) | (0.13) | (0.33) | (0.32) | |
Revenue per Share |
8.06 | 7.88 | 6.91 | 6.60 | |
Operating CF per Share |
0.11 | (0.50) | (0.41) | (0.60) | |
Capex per Share |
(0.27) | (0.17) | (0.37) | (0.32) | |
Capex to Sales |
0.03 | 0.02 | 0.05 | 0.05 | |
Net Profit Margin |
(27.22%) | (35.13%) | (35.79%) | (20.40%) |
Columns are period end dates